0001555280-23-000251.txt : 20231121 0001555280-23-000251.hdr.sgml : 20231121 20231121164147 ACCESSION NUMBER: 0001555280-23-000251 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231121 FILED AS OF DATE: 20231121 DATE AS OF CHANGE: 20231121 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: PECK KRISTIN C CENTRAL INDEX KEY: 0001488267 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35797 FILM NUMBER: 231428815 MAIL ADDRESS: STREET 1: C/O ZOETIS INC. STREET 2: 10 SYLVAN WAY CITY: PARSIPPANY STATE: NJ ZIP: 07054 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Zoetis Inc. CENTRAL INDEX KEY: 0001555280 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 460696167 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 10 SYLVAN WAY CITY: PARSIPPANY STATE: NJ ZIP: 07054 BUSINESS PHONE: 973-822-7000 MAIL ADDRESS: STREET 1: 10 SYLVAN WAY CITY: PARSIPPANY STATE: NJ ZIP: 07054 4 1 wk-form4_1700602885.xml FORM 4 X0508 4 2023-11-21 0 0001555280 Zoetis Inc. ZTS 0001488267 PECK KRISTIN C C/O ZOETIS INC. 10 SYLVAN WAY PARSIPPANY NJ 07054 1 1 0 0 Chief Executive Officer 1 Common Stock 2023-11-21 4 M 0 13000 46.09 A 69843 D Common Stock 2023-11-21 4 S 0 5040 176.4459 D 64803 D Common Stock 2023-11-21 4 S 0 7960 177.0815 D 56843 D Common Stock 796.0368 I 401(k) Stock Option 2023-11-21 4 M 0 13000 0 D Common Stock 13000 283014 D Stock Option 162.07 Common Stock 67148 67148 D The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 15, 2023. The Price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $175.78 to $176.7408, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The Price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $176.78 to $177.67, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Represents the common stock equivalents held in the Zoetis Inc. Savings Plan, a 401(k) plan, as of September 30, 2023. Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. 13,000 options granted February 27, 2015 at an exercise price of $46.09 per option. Each option vests on the third anniversary of the date of grant. Each option expires on the tenth anniversary of the date of grant. 13,382 options granted February 27, 2015 at an exercise price of $46.09 per option; 20,000 options granted February 19, 2016 at an exercise price of $41.83 per option; 32,634 options granted February 14, 2017 at an exercise price of $55.02 per option; 24,642 options granted February 13, 2018 at an exercise price of $73.24 per option; 20,661 options granted February 12, 2019 at an exercise price of $87.51 per option; 55,866 options granted February 11, 2020 at an exercise price of $144.03 per option; 61,078 options granted February 10, 2021 at an exercise price of $160.62 per option; and 54,751 options granted February 8, 2022 at an exercise price of $201.30 per option. Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. Amended and Restated 2013 Equity and Incentive Plan. One-third of each option will vest on the first, second and third anniversaries of the date of grant. /s/ Brenda Santuccio, as Attorney-in-Fact 2023-11-21